ImmunityBio, Inc. IBRX Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s operating lease liability payments due?
- ImmunityBio, Inc. (IBRX) reported operating lease liability payments due of $51.27M in Q1 2026.
- How has ImmunityBio, Inc.'s operating lease liability payments due changed year-over-year?
- ImmunityBio, Inc.'s operating lease liability payments due decreased by 2.7% year-over-year, from $52.68M to $51.27M.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.